Anthony Atala, director of the Institute for Regenerative Medicine at Wake Forest University School of Medicine, reported that stem cells in the amniotic fluid that fills the sac surrounding the fetus may be just as versatile as embryonic stem cells. At the same time they maintain all the advantages that have made adult stem cells such a success.Don't expect the MSM to hype this, folks. We need to do what we can to spread the word. The author points out the blatant and intentional cover-up (his words!) by the New York Times of the advances made in adult stem cells and in stem cells harvested from amniotic fluid.
This has caused great consternation on the part of those seeking increased taxpayer embryonic stem cell funds. The reason is that there are currently no practical applications for this type of cell. There hasn't even been a single clinical trial involving them. Researchers admit we won't have approved embryonic stem cell treatments for at least 10 years.[SNIP]
As stem-cell researcher Malcolm Alison of the University of London told a British newspaper, the amniotic cells "appear to be at least as malleable as embryonic stem cells but without all the ethical baggage."
It is neither paranoia nor exaggeration to say that the New York Times is engaged in a stem-cell cover-up.
Instapundit has already linked the article, so lots of people are going to see it; but not all people in the Lutheran/Christian blogosphere read Instapundit. And, as always, remember to Read the whole thing™. Or, as I prefer to say...
Track with co.mments Links to this post